33.
Kiralj R., Ferreira M.M.C., “A STUDY OF HIV-1 PROTEASE – INHIBITOR INTERMOLECULAR INTERACTIONS BY USING QUANTITATIVE MOLECULAR GRAPHICS AND A PRIORI QSAR”. Caxambu, MG, Brazil, 11-16/11/2001: 1º Simpósio Brasileiro em Química Medicinal, QSAR e Modelagem Molecular: Novas Estratégias em Planejamento Racional de Fármacos [1st Brazilian Symposium on Medicinal Chemistry, QSAR and Molecular Modeling: New Approaches in Drug Design]. Poster APM21.

34.
Kiralj R., Ferreira M.M.C., “A COMBINED CHEMOMETRIC, STRUCTURAL, MOLECULAR GRAPHICS AND MODELING STUDY OF PROGESTOGENS”. Caxambu, MG, Brazil, 11-16/11/2001: 1º Simpósio Brasileiro em Química Medicinal, QSAR e Modelagem Molecular: Novas Estratégias em Planejamento Racional de Fármacos [1st Brazilian Symposium on Medicinal Chemistry, QSAR and Molecular Modeling: New Approaches in Drug Design]. Oral & Poster APM20.

35.
Ribeiro F. A. L., Sabino L. C., Ferreira M.M.C., “QSPR Models to Predict the Organic Carbon-Water Partition Coefficient (Koc) and Bioconcentration Factor (BCF) for Polycyclic Aromatic Hydrocarbons (PAHs)”.Caxambu, MG, Brazil, 11-16/11/2001: 1º Simpósio Brasileiro em Química Medicinal, QSAR e Modelagem Molecular: Novas Estratégias em Planejamento Racional de Fármacos [1st Brazilian Symposium on Medicinal Chemistry, QSAR and Molecular Modeling: New Approaches in Drug Design]. Poster APM17.

36.
Bruni A. T., Ferreira M. M. C., “QSAR Study of Omeprazole and Analogue Compounds as Anti Helicobacter Pylori Agents”. Caxambu, MG, Brazil, 11-16/11/2001:  1º Simpósio Brasileiro em Química Medicinal, QSAR e Modelagem Molecular: Novas Estratégias em Planejamento Racional de Fármacos [1st Brazilian Symposium on Medicinal Chemistry, QSAR and Molecular Modeling: New Approaches in Drug Design]. Poster APM12.

37.
Ribeiro F. A. L., Ferreira M. M. C., “QSAR MODEL OF THE PHOTOTOXICITY OF POLYCYCLIC AROMATIC HYDROCARBONS”. Caxambu, MG, Brazil, 11-16/11/2001: 1º Simpósio Brasileiro em Química Medicinal, QSAR e Modelagem Molecular: Novas Estratégias em Planejamento Racional de Fármacos [1st Brazilian Symposium on Medicinal Chemistry, QSAR and Molecular Modeling: New Approaches in Drug Design]. Poster APM11.

38.
Ferreira M. M. C., “Multivariate QSAR”. Caxambu, MG, Brazil, 11-16/11/2001: 1º Simpósio Brasileiro em Química Medicinal, QSAR e Modelagem Molecular: Novas Estratégias em Planejamento Racional de Fármacos [1st Brazilian Symposium on Medicinal Chemistry, QSAR and Molecular Modeling: New Approaches in Drug Design]. Oral.

The detailed Program Book, is available at the conference site. The Last Circular, is also available at the conference site. The conferece site can be found at:
http://agora.grude.ufmg.br/QuickPlace/brazmedchem/Main.nsf/h_Toc/29559189B339F9AC83256AC30067AA00/?OpenDocument
http://agora.grude.ufmg.br/brazmedchem

Right below are some electronic documents containing useful information about the Brazmedchem meeting.

Brazilian Symposium on Medicinal Chemistry

Announcement:

Dear colleague,

It is our pleasure to announce the first Brazilian interdisciplinary
symposium on Medicinal Chemistry: QSAR and Molecular Modelling,
organised by the Division of Medicinal Chemistry of the Brazilian
Chemical Society, to be held at the Federal University of Minas Gerais,
in Belo Horizonte, from November 11 to 16, 2001.
 The scientific programme will include the following topics:
1. Perspectives in drug discovery and design of antiprotozoan drugs;
2. Receptor-based prediction of binding affinities;
3. Membranes and drug design;
4. Applications of multivariate QSAR;
5. Medicinal chemistry of natural products.

The following speakers have already confirmed their attendance:
1. Christophe Verlinde, USA
  Protein structure-based design of anti-protozoal drugs
2. David W. Boykin, USA
  DNA minor groove binders as antiprotozoan agents
3. Glaucius Oliva, BRA
  Target-directed drug discovery in tropical diseases
4. John Dearden, UK
  QSAR modelling of toxicity of drugs
5. Tudor Oprea, SW
Integrating DMPK and binding affinity predictions: a paradigm shift in
lead discovery
6. Ferran Sanz, Spain
Comparison of biomolecules on the basis of molecular interaction
potentials
7. Gerd Folkers, CH
  Designing the keys and engineering the locks: CAMD approaches in gene
therapy
8. Antonia Tavares do Amaral, BRA
9. Roy Bruns, BRA
  Multivariate planning, data analysis and QSAR
10. Anderson Coser Gaudio, BRA
   Computer simulation of the drug-receptor interaction
11. Hugo Kubinyi, Germany
  Chemical similarity and biological activity
12. Otto Richard Gotllieb, BRA
1999 Nobel Prize nominee
13. João B. Calixto, BRA
The role of natural products in the process of drug discovery and
development
14. Gabriele Cruciani
Application of QSPR models in pharmaceutical research

Abstracts related to these topics are welcome.
The official language will be English.
The deadline for abstract contributions is July 23, 2001.

Please visit our homepage for a continuing update of this programme:
http://www.qui.ufmg.br/~nequim/qsar/brasmedchem.html

    Carlos Montanari
    On behalf of Organising Committee
 

This archive was generated by hypermail 2b29 : Thu Dec 21 2000 - 10:43:05 PST

Dear colleague,

 It is our pleasure to announce the first Brazilian interdisciplinary symposium on Medicinal Chemistry: QSAR and Molecular Modelling, organised by the Division of Medicinal Chemistry of the Brazilian Chemical Society, to be held at the Federal University of Minas Gerais, in Belo Horizonte, from November 11 to 16, 2001. The scientific programme will include the following topics:

Perspectives in drug discovery and design of antiprotozoan drugs

Receptor-based prediction of binding affinities

Membranes and drug design

Applications of multivariate QSAR

Medicinal chemistry of natural products

1. Christophe Verlinde, USA - Protein structure-based design of anti-protozoal drugs

2. David W. Boykin, USA - DNA minor groove binders as antiprotozoan agents

3. Glaucius Oliva, BRA - Target-directed drug discovery in tropical diseases

4. John Dearden, UK - QSAR modelling of toxicity of drugs

5. Tudor Oprea, SW - Integrating DMPK and binding affinity predictions: a paradigm shift in lead discovery

6. Ferran Sanz, Spain - Comparison of biomolecules on the basis of molecular interaction potentials

7. Gerd Folkers, CH - Designing the keys and engineering the locks: CAMD approaches in gene therapy

8. Antonia Tavares do Amaral, BRA

9. Roy Bruns, BRA - Multivariate planning, data analysis and QSAR

10. Anderson Coser Gaudio, BRA - Computer simulation of the drug-receptor interaction

11. Hugo Kubinyi, Germany - Chemical similarity and biological activity

12. Otto Richard Gotllieb, BRA - 1999 Nobel Prize nominee

13. João B. Calixto, BRA - The role of natural products in the process of drug discovery and development

14. Gabriel Cruciani - Application of QSPR models in pharmaceutical research

http://www.qui.ufmg.br/~nequim/qsar/brasmedchem.html

Return to the Division of Medicinal Chemistry What's New Page

7. FIRST BRAZILIAN INTERDISCIPLINARY SYMPOSIUM ON MEDICINAL CHEMISTRY: QSAR AND MOLECULAR MODELLING

It is our pleasure to announce the first Brazilian interdisciplinary symposium on Medicinal Chemistry: QSAR and Molecular Modelling, organised by the Division of Medicinal Chemistry of the Brazilian Chemical Society, to be held at the Federal University of Minas Gerais, in Belo Horizonte, from November 11 to 16, 2001.

The scientific programme will include the following topics:

1. Perspectives in drug discovery and design of antiprotozoan drugs;
2. Receptor-based prediction of binding affinities;
3. Membranes and drug design;
4. Applications of multivariate QSAR;
5. Medicinal chemistry of natural products.

1. Christophe Verlinde, USA
• Protein structure-based design of anti-protozoal drugs

 
2. David W. Boykin, USA
• DNA minor groove binders as antiprotozoan agents

 
3. Glaucius Oliva, BRA
• Target-directed drug discovery in tropical diseases

 
4. John Dearden, UK
• QSAR modelling of toxicity of drugs

 
5. Tudor Oprea, SW
• Integrating DMPK and binding affinity predictions: a paradigm shift in lead discovery

 
6. Ferran Sanz, Spain
• Comparison of biomolecules on the basis of molecular interaction potentials

 
7. Gerd Folkers, CH
• Designing the keys and engineering the locks: CAMD approaches in gene therapy

 
8. Antonia Tavares do Amaral, BRA

 
9. Roy Bruns, BRA
• Multivariate planning, data analysis and QSAR

 
10. Anderson Coser Gaudio, BRA
• Computer simulation of the drug-receptor interaction

 
11. Hugo Kubinyi, Germany
• Chemical similarity and biological activity

 
12. Otto Richard Gotllieb, BRA
• 1999 Nobel Prize nominee

 
13. João B. Calixto, BRA
• The role of natural products in the process of drug discovery and development

 
14. Gabriel Cruciani
• Application of QSPR models in pharmaceutical research

Carlos Montanari
On behalf of Organising Committee